SCHEMBL8909803

SCHEMBL8909803

CC(=O)OCc1[nH]c(C(C)=O)c(C)c1C(C)=O

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.52
CYP3A4 P08684 1/20 0.52
ALDH1A1 P00352 3/20 0.50
MAPK1 P28482 2/20 0.50
NPSR1 Q6W5P4 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
HTT P42858 1/20 0.40
HSD17B10 Q99714 1/20 0.40
XBP1 P17861 1/20 0.38
ATM Q13315 1/20 0.38
BRD4 O60885 1/20 0.38
BRPF1 P55201 1/20 0.38
CREBBP Q92793 1/20 0.38
HPGD P15428 1/20 0.38
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8796711 0.90 LMNA (0.49) CYP1A2CYP3A4ALDH1A1MAPK1NPSR1
SCHEMBL7962367 0.87 HPGD (0.55) CYP1A2CYP3A4ALDH1A1MAPK1NPSR1
SCHEMBL7963533 0.79 RAB9A (0.73) ALDH1A1MAPK1NPSR1SMN1; SMN2NPC1
SCHEMBL8910825 0.77 CYP1A2 (0.57) CYP1A2CYP3A4ALDH1A1MAPK1NPSR1
SCHEMBL8911652 0.75 CYP1A2 (0.44) CYP1A2CYP3A4ALDH1A1MAPK1NPSR1
SCHEMBL13983356 0.75 LMNA (0.54) CYP1A2CYP3A4ALDH1A1MAPK1NPSR1
SCHEMBL10878625 0.71 ALDH1A1 (0.40) ALDH1A1MAPK1HSD17B10XBP1LMNA
SCHEMBL5203823 0.67 ALDH1A1 (1.00) CYP1A2CYP3A4ALDH1A1MAPK1NPSR1
SCHEMBL29951621 0.66 NPSR1 (0.61) CYP1A2CYP3A4ALDH1A1MAPK1NPSR1
SCHEMBL14239801 0.66 ALDH1A1 (0.35) CYP1A2ALDH1A1L3MBTL1HTTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5679694-A LOW TOXICITY AGAINST NORMAL CELL LINES THE WELLCOME FOUNDATION LTD. (GB) 1997-10-21 US disclosed
EP-0651750-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1995-05-10 EP disclosed
WO-1994002483-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-02-03 WO disclosed